(Q33198730)

English

Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

0 references

placebo-controlled trial

1 reference

based on heuristic

inferred from title

11

object named as

Christoph Bode

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

8

object named as

Dirk Ubbink

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

3

object named as

Dink A Legemate

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

author name string

Niels van Royen

1

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Jan J Piek

2

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Wolfgang Schaper

4

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Jacques Oskam

5

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Bektas Atasever

6

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Michiel Voskuil

7

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Stephan H Schirmer

9

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Ivo Buschmann

10

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Eva E Buschmann

12

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Vascular Medicine

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

191-196

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Medical treatment of peripheral arterial disease and claudication

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM496OA

21 January 2018

Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM496OA

21 January 2018

Mechanisms of angiogenesis and arteriogenesis

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM496OA

21 January 2018

Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM496OA

21 January 2018

Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM496OA

21 January 2018

Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM496OA

21 January 2018

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM496OA

21 January 2018

Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM496OA

21 January 2018

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM496OA

21 January 2018

Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM496OA

21 January 2018

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM496OA

21 January 2018

Vascular endothelial growth factor enhances atherosclerotic plaque progression

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM496OA

21 January 2018

Clinical, angiographic and hemodynamic predictors of recruitable collateral flow assessed during balloon angioplasty coronary occlusion.

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM496OA

21 January 2018

The dissociation of GM-CSF efficacy from toxicity according to route of administration: a pharmacodynamic study

1 reference

https://api.crossref.org/works/10.1191%2F1358863X03VM496OA

21 January 2018

Identifiers

10.1191/1358863X03VM496OA

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33198730&oldid=2097644380"